Filter Results
:
(921)
Show Results For
-
All HBS Web
(921)
- People (1)
- News (168)
- Research (513)
- Multimedia (6)
- Faculty Publications (251)
Show Results For
-
All HBS Web
(921)
- People (1)
- News (168)
- Research (513)
- Multimedia (6)
- Faculty Publications (251)
- Research Summary
Overview
Patient Portals: The Provider Role
Patient portals are widespread, but evidence of impact is limited. In this study, we use a large dataset spanning 2 years and >1 million patients across 650 primary care practices to explore the "other side" of portals: health... View Details
Patient portals are widespread, but evidence of impact is limited. In this study, we use a large dataset spanning 2 years and >1 million patients across 650 primary care practices to explore the "other side" of portals: health... View Details
- Awards
CAHME – George and Regi Herzlinger Award for the Development of Educational Skills Focusing on Invention, Evaluation, and Adoption of Innovation in Healthcare.
Established the George and Regi Herzlinger Award for the Development of Educational Skills Focusing on Invention, Evaluation, and Adoption of Innovation in Healthcare from the Commission on the Accreditation of Health Management Education (CAHME).
View Details
- October 2001 (Revised November 2002)
- Case
Herman Miller(B): Creating Innovation Streams
By: Sandra J. Sucher and Stacy McManus
In 1997, Mike Volkema faced the difficulty of attempting to revitalize a once dynamic organization. Volkema wondered how he could incorporate advances made within subsidiaries, such as Miller SQA's business model innovation, into the company as a whole while also...
View Details
Keywords:
Innovation and Invention;
Innovation and Management;
Product Design;
Product Development;
Product;
Supply Chain Management;
Business Model;
Service Delivery;
Customer Value and Value Chain;
Manufacturing Industry;
Consumer Products Industry
Sucher, Sandra J., and Stacy McManus. "Herman Miller(B): Creating Innovation Streams." Harvard Business School Case 602-024, October 2001. (Revised November 2002.)
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing Agreements In Biopharmacy;
Licensing;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Entrepreneurship;
Health Care and Treatment;
Acquisition;
Innovation and Invention;
Biotechnology Industry;
Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- March 2013 (Revised May 2013)
- Case
Omar Ishrak: Building Medtronic Globally
By: Bill George and Natalie Kindred
Omar Ishrak, Medtronic's first non-American CEO, aims to reinvigorate the medical device maker's growth by focusing on emerging markets, therapy innovation, and creative business models. In 2012, budget constraints in mature economies, the lack of new medical therapies...
View Details
Keywords:
Healthcare;
Medical Devices;
Medtronic;
Globalization;
Innovation;
Reverse Innovation;
Leadership;
Multinational Firms and Management;
Globalized Markets and Industries;
Management Teams;
Business Model;
Emerging Markets;
Global Strategy;
Health Care and Treatment;
Acquisition;
Innovation and Invention;
Manufacturing Industry;
Medical Devices and Supplies Industry;
China
George, Bill, and Natalie Kindred. "Omar Ishrak: Building Medtronic Globally." Harvard Business School Case 413-065, March 2013. (Revised May 2013.)
- Web
Creating Inclusive Recruiting Events in a Time of Innovation - Recruiting
Insights & Advice 14 Jul 2020 Creating Inclusive Recruiting Events in a Time of Innovation Becca Carnahan Author HBS Team tag All Industries All Locations Diversity, Inclusion, & Belonging Recruiting Advice...
View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
article, “Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting,” is co-authored by Harvard Business School Professor Karim R. Lakhani and seven colleagues with expertise View Details
- July 2011
- Article
Unexploited Efficiencies in Higher Education
By: Henry C. Eyring
In "Unexploited Efficiencies in Higher Education," Henry C. Eyring argues that one way that the U.S. can compete globally in college attainment is to decrease cost-per-graduate. He explains how many stakeholders in higher education stand to benefit from unexploited...
View Details
Keywords:
Performance Measurement;
Innovation;
Control Systems;
Education;
Performance Evaluation;
Innovation and Invention;
Education Industry;
United States
Eyring, Henry C. "Unexploited Efficiencies in Higher Education." Art. 1. Contemporary Issues in Education Research 4, no. 7 (July 2011): 1–18. (Best Paper Award, March 2011 Clute Institute International Economic Conference.)
- November 2022
- Case
Ajax Health: A New Model for Medical Technology Innovation
By: Regina E. Herzlinger and Ben Creo
This case teaches key success factors for both startup and established MedTech firms. It examines how to structure a firm to maximize innovation and financial returns with organizational structures that better align the incentives for the different skill sets...
View Details
Keywords:
Business Startups;
Success;
Innovation Strategy;
Mergers and Acquisitions;
Market Entry and Exit;
Financial Strategy;
Business Model;
Partners and Partnerships;
Entrepreneurship;
Private Equity;
Technology Industry;
Medical Devices and Supplies Industry
Herzlinger, Regina E., and Ben Creo. "Ajax Health: A New Model for Medical Technology Innovation." Harvard Business School Case 323-043, November 2022.
- 09 Aug 2010
- Research & Ideas
How to Speed Up Energy Innovation
Is there a special sauce for stimulating innovation in the energy sector, a concoction to spur cost-effective developments toward solving the climate change problem? HBS professor Rebecca Henderson doesn't...
View Details
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing;
Licensing Agreements In Biopharmacy;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Partners and Partnerships;
Entrepreneurship;
Growth and Development Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- Web
The Global Health Delivery Project - Institute For Strategy And Competitiveness
Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S. Competitiveness Project FSG Shared Value Initiative Social Progress Imperative AllWorld Network...
View Details
- 27 Sep 2013
- Working Paper Summaries
The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For...
View Details
Keywords:
Healthcare;
Technological And Scientific Innovation;
Cancer Care In The U.S.;
Cancer Treatment;
Precision Medicine;
Personalized Medicine;
Data Sharing;
Technological Innovation;
Analytics and Data Science;
Health Disorders;
Medical Specialties;
Research and Development;
Customization and Personalization;
Health Industry;
United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- 07 Jul 2008
- Research & Ideas
Innovation Corrupted: How Managers Can Avoid Another Enron
"In the end, Enron was at the center of a truly delinquent society. Once Enron's ethical drift took hold, its collapse was only a matter of time," says HBS professor emeritus Malcolm S. Salter. As he explains in this Q&A and...
View Details
- Article
Dissecting Costs of CT Study: Application of TDABC (Time-driven Activity-based Costing) in a Tertiary Academic Center
By: Robert S. Kaplan, Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima and Vivian S. Lee
The lack of understanding the true costs (not charges) of delivering health care services poses tremendous challenges in the containment of health care costs. In this study, we applied an established cost accounting method, time-driven activity-based costing (TDABC),...
View Details
Keywords:
Healthcare Costs;
Medical Imaging;
Computed Tomography;
Activity-Based Costing;
Cost Accounting;
Activity Based Costing and Management;
Health Care and Treatment;
Performance Efficiency;
Health Industry
Kaplan, Robert S., Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima, and Vivian S. Lee. "Dissecting Costs of CT Study: Application of TDABC (Time-driven Activity-based Costing) in a Tertiary Academic Center." Academic Radiology 24, no. 2 (February 2017): 200–208.
- 02 Apr 2015
- Research & Ideas
Digital Initiative Summit: Freeing Patient Data to Enable Innovation
mending information gap in health care. Majmudar, whose own company is working at the intersection of health data and wearables, pushed future innovators to focus on ideas that will have measurable impacts...
View Details
- 01 Sep 2020
- News
Turning Point: Change, Stat
The silver lining in all of this is that people have realized the emperor has no clothes. For decades, we’ve recognized that healthcare innovates dramatically slower than other...
View Details
- February 2022 (Revised April 2022)
- Case
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Tuna Cem Hayirli
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant. The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
Keywords:
COVID;
Caregiving;
Healthcare;
Access;
Change;
Retail;
Health;
Health Care and Treatment;
Organizational Change and Adaptation;
Transformation;
Health Industry;
Retail Industry
Kanter, Rosabeth Moss, and Tuna Cem Hayirli. "CVS Health: Prescription for Transformation." Harvard Business School Case 322-091, February 2022. (Revised April 2022.)
- October 2022 (Revised January 2024)
- Case
mPharma: Scaling Access to Affordable Primary Care in Africa
By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine...
View Details
Keywords:
Africa;
Pharmaceutical Companies;
Pharmacy Benefit Manager;
Health Care;
Health Care And Treatment;
Health Care Costs;
Health Care Delivery;
Health Care Entrepreneurship;
Telehealth;
Health Equity;
Corporate Strategy;
Social Entrepreneurship;
Equity;
Growth and Development Strategy;
Expansion;
Product Launch;
Customer Value and Value Chain;
Social Enterprise;
Multinational Firms and Management;
Pharmaceutical Industry;
Health Industry;
Africa
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised January 2024.)